<DOC>
	<DOC>NCT00344955</DOC>
	<brief_summary>We wanted to test the acute effect of HMG-CoA reductase inhibition (atorvastatin) on renal hemodynamics, renal tubular function and vasoactive hormones on healthy subjects.</brief_summary>
	<brief_title>Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Both men and women Age: Between 2050 BMI&lt;30 Clinical signs or history of disease of heart, lungs, kidneys or endocrine organs. Abnormal lab. tests( haemoglobin, pl. sodium, pl. potassium, pl.creatinine, pl.bilirubin, pl.ALAT, pl. cholesterol, blood glucose) Albuminuria or glucosuria Cancer Art. hypertension Alcohol abuse Medical treatment, except oral contraceptives Pregnancy or breast feeding Blood donation less than 1 month before study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>HMG-COA reductase inhibition</keyword>
	<keyword>GFR</keyword>
	<keyword>RPF</keyword>
	<keyword>FE</keyword>
	<keyword>CL</keyword>
</DOC>